2,338
Views
24
CrossRef citations to date
0
Altmetric
ARTICLES

Effects of antibiotic therapy on the gastrointestinal microbiota and the influence of Lactobacillus casei

, , , , , , , & show all
Pages 315-330 | Received 13 Jan 2012, Accepted 25 Apr 2012, Published online: 29 May 2012

Figures & data

Table 1. Characterisation of participant groups.

Table 2. Primers and TaqMan®-probes targeting 16rRNA coding regions of bacteria.

Table 3. Primers targeting 16rRNA coding regions of bacteria (SYBR® Green) and butyryl-CoA CoA transferase genes.

Table 4. Group distribution concerning antibiotic-associated diarrhoea (AAD) and Clostridium difficile infection (CDI).

Figure 1. 16S rRNA qPCR of (A) total bacteria, (B) Clostridium Cluster IV, (C) Clostridium cluster XI, (D) Bifidobacterium spp., (E) Enterobacteriaceae, (F) Lactobacillus spp.

(A: antibiotic treatment; AP: antibiotic treatment and intake of a probiotic drink containing Lactobacillus casei Shirota; P: intake of a probiotic drink containing L. casei Shirota; C: control group; 1: day 0, 2: day 3, 3: day 5).

Figure 1. 16S rRNA qPCR of (A) total bacteria, (B) Clostridium Cluster IV, (C) Clostridium cluster XI, (D) Bifidobacterium spp., (E) Enterobacteriaceae, (F) Lactobacillus spp.(A: antibiotic treatment; AP: antibiotic treatment and intake of a probiotic drink containing Lactobacillus casei Shirota; P: intake of a probiotic drink containing L. casei Shirota; C: control group; 1: day 0, 2: day 3, 3: day 5).
Figure 2. PCR-DGGE fingerprinting of 16S rRNA coding regions amplified with primer pair 341GC-518.

(A: antibiotic treatment; AP: antibiotic treatment and intake of a probiotic drink containing Lactobacillus casei Shirota; P: intake of a probiotic drink containing L. casei Shirota; C: control group; 1: day 0, 3: day 5, SL: standard line).

Figure 2. PCR-DGGE fingerprinting of 16S rRNA coding regions amplified with primer pair 341GC-518.(A: antibiotic treatment; AP: antibiotic treatment and intake of a probiotic drink containing Lactobacillus casei Shirota; P: intake of a probiotic drink containing L. casei Shirota; C: control group; 1: day 0, 3: day 5, SL: standard line).
Figure 3. Percentage of bacterial subgroups in relation to the analysed bacteria. In patients under antibiotic treatment, there were more bacteria which cannot be identified by the primers used in this study.

(A: antibiotic treatment; AP: antibiotic treatment and intake of a probiotic drink containing Lactobacillus casei Shirota; P: intake of a probiotic drink containing L. casei Shirota; C: control group; 1: day 0, 2: day 3, 3: day 5).

Figure 3. Percentage of bacterial subgroups in relation to the analysed bacteria. In patients under antibiotic treatment, there were more bacteria which cannot be identified by the primers used in this study.(A: antibiotic treatment; AP: antibiotic treatment and intake of a probiotic drink containing Lactobacillus casei Shirota; P: intake of a probiotic drink containing L. casei Shirota; C: control group; 1: day 0, 2: day 3, 3: day 5).
Figure 4. Abundance of butyryl-CoA CoA transferase genes in group A (antibiotic treatment), AP (antibiotic treatment and intake of a probiotic drink containing Lactobacillus casei Shirota), P (intake of a probiotic drink containing L. casei Shirota) and C (control group) (1: day 0, 2: day 5, 3: day 5). Amplification was done by 16S rRNA qPCR with primer pair BCoATscrF/R.
Figure 4. Abundance of butyryl-CoA CoA transferase genes in group A (antibiotic treatment), AP (antibiotic treatment and intake of a probiotic drink containing Lactobacillus casei Shirota), P (intake of a probiotic drink containing L. casei Shirota) and C (control group) (1: day 0, 2: day 5, 3: day 5). Amplification was done by 16S rRNA qPCR with primer pair BCoATscrF/R.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.